Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

BERLIN, Jan 23 (Reuters) - BMW Chief Executive Oliver Zipse will not extend his contract beyond the summer of next year, when it expires, Germany's manager magazin reported on Thursday, citing a ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

It’s increasingly clear that Ange Postecoglou has taken Spurs and somehow – genuinely quite impressively, really – made them more Spurs than they have ever been before. What you have ...

Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based adventure connoisseur, a lover of terrible movies and an enthusiastic yet mediocre cook. A CNET editor from 2013 to 2024, Ry ...

Editorial note: This post may contain links to internet offers and services from which Allconnect receives a commission. Broadband partners and the associated compensation do not influence our ...

Trey Paul is a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at the broadband marketplace Allconnect, as well as working with clients like ...